Our traditional Indian medicine was long criticized for its inefficiency to showcase proper scientific validation of drugs. Despite the Ayurveda, Unani and Siddha being popular among Indians, the traditional medicine systems couldn’t compete against Allopathy which is backed by scientific evidence. But for now the tremendous change has come, as country’s premier institute, Centre for Cellular and Molecular Biology (CCMB), decided to conduct research and documentation of plant-based medicines in India.
An MoU has been agreed by CCMB with Ghaziabad-based Indian Pharmacopeia Commission (IPC) in order to take up documentation, validation and characterization of Indian herbal drugs. CCMB Director Dr RK Mishra stated that in order to solidify the traditional Indian knowledge of thousands of years the scientific validation and characterization of herbal drugs will be done that not only helps in authentication of such drugs but also bring credibility to the industry.
The CCMB and IPC research on plant-based drugs could provide the required scientific and data-based evidence on plant-based drugs, especially for Ayush. To facilitate the regulatory process and to boost the Indian medicine sector the study will take place on herbal medicines that is based on modern scientific methods.
The agreement was signed by Secretary-cum-Scientific Director, IPC, Dr GN Singh and Dr Mishra.